Target organ profiles in toxicity studies supporting human dosing: Does severity progress with longer duration of exposure?
- 1 December 2015
- journal article
- research article
- Published by Elsevier BV in Regulatory Toxicology and Pharmacology
- Vol. 73 (3), 737-746
- https://doi.org/10.1016/j.yrtph.2015.10.021
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Target organ profiles in toxicity studies supporting human dosing: An assessment of recovery and chronic dosingRegulatory Toxicology and Pharmacology, 2014
- Characterization of the dose decrement in regulatory rat pesticide toxicity feeding studiesRegulatory Toxicology and Pharmacology, 2013
- Target organ toxicities in studies conducted to support first time in man dosing: An analysis across species and therapy areasRegulatory Toxicology and Pharmacology, 2013
- Study parameters influencing NOAEL and LOAEL in toxicity feeding studies for pesticides: Exposure duration versus dose decrement, dose spacing, group size and chemical classRegulatory Toxicology and Pharmacology, 2011
- Evaluation of time extrapolation factors based on the database RepDoseToxicology Letters, 2011
- Safety evaluation to support first-in-man investigations II: Toxicology studiesRegulatory Toxicology and Pharmacology, 2008
- First dose of potential new medicines to humans: how animals helpNature Reviews Drug Discovery, 2004
- Concordance of the Toxicity of Pharmaceuticals in Humans and in AnimalsRegulatory Toxicology and Pharmacology, 2000
- Hepatotoxicity in drug development: detection, significance and solutionsJournal of Hepatology, 1997
- Target organ toxicityToxicology Letters, 1981